Stocktoria
Adicet Bio, Inc. ACET
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-01-26
Chart by TradingView
1/9
Piotroski F — financial health
-4.89
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$122.1M | -$127.6M | -$152.0M | -$72.6M | -$61.4M |
| Net income | -$116.8M | -$117.1M | -$142.7M | -$69.8M | -$62.0M |
| Operating cash flow | -$95.2M | -$92.4M | -$93.7M | -$44.8M | -$51.1M |
| Free cash flow | -$97.0M | -$93.5M | -$98.2M | -$61.5M | -$64.1M |
| Total assets | $192.4M | $220.2M | $207.3M | $330.7M | $338.9M |
| Total liabilities | $33.1M | $33.6M | $37.1M | $38.4M | $35.8M |
| Shareholders' equity | $159.2M | $186.6M | $170.2M | $292.3M | $303.1M |
| Ratios | |||||
| Return on assets | -60.7% | -53.2% | -68.8% | -21.1% | -18.3% |
| Return on equity | -73.4% | -62.8% | -83.8% | -23.9% | -20.5% |
| Current ratio | 7.47 | 9.29 | 8.41 | 13.25 | 17.31 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 232,591 | $1.6M |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -4.89 (distress)
- Working capital / assets 0.725
- Retained earnings / assets -3.196
- EBIT / assets -0.635
- Equity / liabilities 4.803
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001720580 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.